Details
Stereochemistry | RACEMIC |
Molecular Formula | 2C17H23NO2.2ClH.H2O |
Molecular Weight | 637.677 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2.CCOC(=O)[C@@]3(CCC=C[C@H]3N(C)C)C4=CC=CC=C4
InChI
InChIKey=WHYVWQHDUOALSV-UMJMSJQKSA-N
InChI=1S/2C17H23NO2.2ClH.H2O/c2*1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3;;;/h2*5-8,10-12,15H,4,9,13H2,1-3H3;2*1H;1H2/t2*15-,17+;;;/m11.../s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The opiate-like action of tilidine is mediated by metabolites. | 1978 Sep |
|
Antagonism between tilidine and naloxone on cerebral potentials and pain ratings in man. | 1983 Mar 4 |
|
[Erroneous intravenous injection of adrenaline]. | 1998 May 29 |
|
Actions of tilidine and nortilidine on cloned opioid receptors. | 2005 Jan 4 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15627429
The selectivity of tilidine and nortilidine for human opioid and opioid-like receptors stably expressed in CHO-K1 cells, using the inhibition of the forskolin (FK)-induced accumulation of cAMP as the endpoint was measured. In cells expressing the Mu opioid receptor, tilidine and nortilidine inhibited cAMP accumulation with IC50 of 11 microM and 110 nM, respectively.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Y757T3419R
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | |||
|
69459534
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | |||
|
SUB69009
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | |||
|
100000134951
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | |||
|
255733-17-6
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | |||
|
m10864
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID70180262
Created by
admin on Fri Dec 15 19:04:51 GMT 2023 , Edited by admin on Fri Dec 15 19:04:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD